JP2022526675A5 - - Google Patents

Info

Publication number
JP2022526675A5
JP2022526675A5 JP2021560231A JP2021560231A JP2022526675A5 JP 2022526675 A5 JP2022526675 A5 JP 2022526675A5 JP 2021560231 A JP2021560231 A JP 2021560231A JP 2021560231 A JP2021560231 A JP 2021560231A JP 2022526675 A5 JP2022526675 A5 JP 2022526675A5
Authority
JP
Japan
Prior art keywords
sub
formula
dichlorophenyl
glucitol
deoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021560231A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022526675A (ja
JP7622338B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/057683 external-priority patent/WO2020207753A1/en
Publication of JP2022526675A publication Critical patent/JP2022526675A/ja
Publication of JP2022526675A5 publication Critical patent/JP2022526675A5/ja
Application granted granted Critical
Publication of JP7622338B2 publication Critical patent/JP7622338B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021560231A 2019-04-11 2020-03-19 2-(3,5-ジクロロフェニル)-6-ベンズオキサゾールカルボン酸1-デオキシ-1-メチルアミノ-d-グルシトールの製造方法 Active JP7622338B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19382273.1 2019-04-11
EP19382273 2019-04-11
PCT/EP2020/057683 WO2020207753A1 (en) 2019-04-11 2020-03-19 Process for preparing 1-deoxy-1-methylamino-d-glucitol 2-(3,5-dichlorophenyl)-6-benzoxazolecarboxylate

Publications (3)

Publication Number Publication Date
JP2022526675A JP2022526675A (ja) 2022-05-25
JP2022526675A5 true JP2022526675A5 (enExample) 2023-03-27
JP7622338B2 JP7622338B2 (ja) 2025-01-28

Family

ID=66240025

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021560231A Active JP7622338B2 (ja) 2019-04-11 2020-03-19 2-(3,5-ジクロロフェニル)-6-ベンズオキサゾールカルボン酸1-デオキシ-1-メチルアミノ-d-グルシトールの製造方法

Country Status (10)

Country Link
US (1) US12116352B2 (enExample)
EP (1) EP3953339B1 (enExample)
JP (1) JP7622338B2 (enExample)
CN (1) CN113874359B (enExample)
AR (1) AR118647A1 (enExample)
ES (1) ES2991081T3 (enExample)
HR (1) HRP20241374T1 (enExample)
HU (1) HUE068975T2 (enExample)
PL (1) PL3953339T3 (enExample)
WO (1) WO2020207753A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113372290A (zh) * 2021-05-21 2021-09-10 遵义医科大学 一种药物Tafamidis的合成方法
CN113277993B (zh) * 2021-06-06 2023-07-21 湖南第一师范学院 一种Tafamidis及其衍生物的合成方法
CN113735792B (zh) * 2021-09-22 2024-10-18 上海新礼泰药业有限公司 氯苯唑酸葡胺及其中间体的制备方法
KR102657823B1 (ko) * 2022-03-10 2024-04-16 고려대학교 산학협력단 타파미디스의 신규 합성법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2800237C (en) * 2002-12-19 2016-05-17 The Scripps Research Institute Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
JP2006513250A (ja) 2003-01-28 2006-04-20 中国科学院上海薬物研究所 アラニン系化合物、その製造方法及び用途
RU2586330C2 (ru) 2011-09-16 2016-06-10 Пфайзер Инк. Твердые формы ингибитора диссоциации транстиретина
US9499527B2 (en) * 2012-05-10 2016-11-22 Cellix Bio Private Limited Compositions and methods for the treatment of familial amyloid polyneuropathy
PT4349406T (pt) * 2014-09-08 2026-02-04 Pfizer Formas sólidas cristalinas de 6-carboxi-2-(3,5-diclorofenil)-benzoxazol para utilização como medicamento
CN107344927A (zh) 2016-05-05 2017-11-14 苏州晶云药物科技有限公司 Tafamidis葡甲胺盐的晶型E及其制备方法和用途

Similar Documents

Publication Publication Date Title
JP2022526675A5 (enExample)
JP5426693B2 (ja) アゴメラチンハロゲン化水素複合体及びその製造方法
FR2867778A1 (fr) Utilisation de derives d'indazolecarboxamides pour la preparation d'un medicament destine au traitement et a la prevention du paludisme
JP2018529687A5 (enExample)
CA2791482A1 (fr) Derives de cetobenzofurane ainsi que leur procede de synthese et les intermediaires
WO2012147019A1 (en) An improved process for the preparation of silodosin
EP3484895A1 (en) Solid state forms of crisaborole
WO2012010788A1 (fr) Procede de preparation de derives d'amino-benzoyl-benzofurane
NO20085417L (no) Krystallinske former av 11beta-(4-acetylfenyl)-20,20,21,21,21-pentafluor-17-hydroksy-19-nor-17alfa-pregna-4,9-dien-3-on
RU2013132424A (ru) Полиморфные формы азенапин малеата и способы их получения
HRP20241374T1 (hr) Postupak priprave 1-deoksi-1-metilamino-d-glucitol-2-(3,5-diklorfenil)-6-benzoksazolkarboksilata
JP2024530795A5 (enExample)
JP2014508805A (ja) ペメトレキセド塩の製造方法
JP2021517171A5 (enExample)
EP2516412A1 (en) Processes for the purification of lubiprostone
JP2018508549A5 (enExample)
RU2009115852A (ru) Способ получения абакавира
JPWO2023058645A5 (enExample)
CN113637003A (zh) 一种制备2-氨基-6-(哌啶-4-酰基)吡啶衍生物的方法
RU2399625C2 (ru) Монолизиновые соли производных азола
CN104447447A (zh) 一个新的化合物及其制备方法和消除方法
WO2005019199A1 (en) Amorphous duloxetine hydrochloride
CN108929227B (zh) 一种苄卤氧化自偶联合成芳香苄酯的方法
JP2025507801A5 (enExample)
JP2007522151A5 (enExample)